Table 3 Clinical and biological HIV parameters of HIV-positive pregnant women
Variables | HIV+ (n = 62) |
|---|---|
n (column %) | |
Time since HIV diagnosis (n = 35) | |
Median time in years (IQR) | 0.23 (0.02–3.5) |
< 1 year | 22 (62.9%) |
1–4 years | 7 (20%) |
5–9 years | 5 (14.3%) |
10 years and more | 1 (2.9%) |
ART initiated (n = 61) | |
Yes | 37 (60.7%) |
No | 24 (39.3%) |
Time since ART initiation (n = 35) | |
Median time in years (IQR) | 0.23 (0.02–3.5) |
< 1 year | 22 (62.9%) |
1–4 years | 7 (20%) |
5–9 years | 5 (14.3%) |
10 years and more | 1 (2.9%) |
CD4 counts (n = 31) in cells/mm3 | |
Median (IQR) | 534 (255–688) |
< 50 | 1 (3.2%) |
50–99 | 1 (3.2%) |
100–199 | 4 (12.9%) |
200–299 | 2 (6.5%) |
300–399 | 4 (12.9%) |
400–499 | 3 (9.7%) |
500 and above | 16 (51.6%) |
CTX taken (n = 48) | |
Yes | 15 (31.3%) |
No | 33 (68.8%) |
Viral load in copies/ml (n = 37) | |
Median (range) | 384 (0–654,000) |
0 | 13 (35.1%) |
1–99 | 2 (5.4%) |
100–999 | 8 (21.6%) |
1000–9999 | 7 (18.9%) |
10,000–99,999 | 4 (10.8%) |
> 100,000 | 3 (8.1%) |